Stockholders’ Equity |
3 Months Ended |
|---|---|
Dec. 29, 2024 | |
| Equity [Abstract] | |
| Stockholders’ Equity |
Note 7 - Stockholders’ Equity
Dividends
No dividends were declared or paid during the three months ended December 29, 2024 or December 31, 2023.
Common stock
On September 22, 2021, the Company announced authorization of a $1 million stock repurchase program. The shares authorized to be repurchased under the repurchase program may be purchased from time to time at prevailing market prices, through open market transactions or in negotiated transactions, depending upon market conditions and subject to Rule 10b-18 as promulgated by the SEC.
During the three months ended December 29, 2024 and December 31, 2023, there were zero common shares repurchased under the program.
During the three months ended December 31, 2023, the Company issued 60,623 shares to Danny Schoening and Karen Hawkins in settlement of 81,000 performance shares which vested during the three months. The shares were issued net of 20,377 shares withheld for taxes.
During the three months ended December 29, 2024, the Company issued 22,800 restricted shares to the three independent board members which will vest on January 1, 2026.
As of December 29, 2024 and September 29, 2024, the total issued and outstanding common shares were 6,896,738 and 6,873,938, respectively.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|